Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas

Blood

Volumn 92, Issue 1, 1998, Pages 76-82

  Gisselbrecht, Christian ^a   Gaulard, Philippe ^b   Lepage, Eric ^b   Coiffier, Bertrand ^b   Brière, Josette ^b   Haioun, Corinne ^b   Cazals Hatem, Dominique ^b   Bosly, André ^b   Xerri, Luc ^b   Tilly, Hervé ^b   Berger, Françoise ^b   Bouhabdallah, Reda ^b   Diebold, Jacques ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOGUAZONE; MITOXANTRONE; PIRARUBICIN; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; T LYMPHOCYTE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; T-LYMPHOCYTES;

EID: 18744420893     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Greer JP, York JC, Cousar JB, Mitchell RT, Flexner JM, Collins RD, Stein RS: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J Clin Oncol 2:788, 1984
2. Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J, for the GELA: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH84 regimen. Ann Oncol 1:45, 1990
3. Melnyk A, Rodriguez A, Pugh WC, Cabanillas F: Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 89:4514, 1997
4. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 89:3909, 1997
5. Cheng AL, Chen YC, Wang CH, Su IJ, Hsieh HC, Chang JY, Hwang WS, Su WC, Liu TW, Tien HF, Tsai W, Shen MC, Liu CH: Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades. Should peripheral T-cell lymphoma be considered separately? J Clin Oncol 7:725, 1989
6. Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVita VT Jr: T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med 100:543, 1984
7. Watanabe S, Shimosato Y, Shimoyama M: Lymphoma and leukemia of T-lymphocytes, in Sommers SC, Rosen P (eds): Pathology Annual 1981 (part 2). New York, NY, Appleton-Century-Crofts, 1981, p 155
8. Stansfeld AG, Diebold J, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, Van Unnik JAM, Mioduszewska O, Wright DH: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
9. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary M, Delsol G, De Wolf-Peeters C, Falini B, Garter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
10. Kwak LW, Wilson M, Weiss LM, Goggett R, Dorfman RF, Warnke RA, Horning SJ: Similar outcome of treatment of B-cell and T-cell diffuse large cell lymphomas: The Stanford experience. J Clin Oncol 9:1426, 1991
11. Armitage JO, Vose JM, Linder J, Weisenburger D, Harrington D, Casey J, Bierman P, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, Johnson S, Pevnick W, Packard WM, Okerbloom J, Thompson RF, Langdon RM, Soori G, Peterson C, Purtilo D: Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J Clin Oncol 7:1783, 1989
12. Lippman SM, Miller TP, Spier CM, Slymen DJ, Grogan TM: The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype. Blood 72:436, 1988
13. Weiss LM, Crabtree GS, Rouse RV, Warnke RA: Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol 118:316, 1985
14. Liang R, Todd D, Chan TK, Wong KL, Ho F, Loke SL: Peripheral T-cell lymphoma. J Clin Oncol 5:750, 1987
15. Weisenburger DD, Linder J, Armitage JO: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. Hematol Oncol 5:175, 1987
16. Pinkus GS, O'Hara CJ, Said JW: Peripheral post-thymic T-cell lymphomas: A spectrum of disease. Cancer 65:971, 1990
17. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
18. Tobinai K, Minato K, Ohtsu T, Murai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M: Clinicopathologic, immunophenotypic and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 72:1000, 1988
19. Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Hun Kim: Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41:578, 1978
20. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
21. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N: LNH84 regimen: A multicenter study of intensive chemother- apy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018, 1989
22. Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F: Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. J Clin Oncol 15:1131, 1997
23. Bosly A, Lepage E, Dupriez B, Herbrecht R, Fillet G, Divine M, Nouvel C, Tilly H, Bordessoule D, Gaulard P, Gisselbrecht C: Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A GELA study. Br J Haematol 83:546, 1996 (abstr)
24. Bastion Y, Blay JY, Divine M, Brice P, Bordessoule D, Sebban C, Blanc M, Tilly H, Lederlin P, Deconinck E, Salles B, Dumontet C, Brière J, Coiffier B: Elderly patients with aggressive lymphoma survive longer if treated with a curative intent. A GELA study on 453 patients older than 69 years. J Clin Oncol 15:2945, 1997
25. Tilly H, Gaulard P, Lepage E, Dumontet C, Diebold J, Plantier I, Berger F, Symann M, Petrella T, Lederlin P, Brière J: Primary anaplastic large-cell lymphoma in adults. Clinical presentation, immunophenotype, and outcome. Blood 90:3727, 1997
26. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
27. Cox DR: Regression models and life-tables, J R Stat Soc 34:187, 1972
28. Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M: Cytotoxic cell antigen expression in anaplastic large cells lymphoma of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin. Blood 89:980, 1997
29. Foss ES, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer JA, Hummel M, Stein H: Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88:4005, 1996
30. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79:1789, 1992
31. Foss HD, Anagnostopoulos I, Herbst H, Grebe M, Ziemann K, Hummel M, Stein H: Patterns of cytokine gene expression in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 85:2862, 1995
32. Jaffe ES, Chan JKC, Ih Jen Su, Frizzera G, Mon S, Feller AC, Ho FCS: Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis and epidemiology. Am J Surg Pathol 20:103, 1996
33. Kanavaros P, Leses MC, Brière J, Divine M, Galateau, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688, 1993
34. Schmitt-Graff A, Hummel M, Zemlin M, Schneider T, Ulrich R, Heise W, Zeit M, Riecken EO, Stein H: Intestinal T-cell lymphoma: A reassessment of cytomorphological and phenotypic features in relation to patterns of small bowel remodeling. Virchows Arch 429:27, 1996
35. Gonzalez CL, Medeiros U, Braziel RM, Jaffe ES: T-cell lymphoma involving subcutaneous tissue: A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am Surg J Pathol 15:17, 1991
36. Gaulard P, Bourquelot P, Kanavaros P, Haioun C, Le Couedic JP, Divine M, Goossens M, Zafrani ES, Farcet JP, Reyes F: Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gd T-cell lymphomas. Am J Pathol 137:617, 1990
37. Cooke CB, Krenacs L, Stetler-Stevensen M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES: Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gd T-cell origin. Blood 88:4265, 1996
38. Archimbaud E, Coiffier B, Bryon PA, Vasselon C, Brizard CP, Viala JJ: Prognostic factors in angioimmunoblastic lymphadenopathy. Cancer 59:208, 1987
39. Siegert W, Agthe A, Griesser H, Schwerdtfeger R, Brittinger G, Engelhard M, Kuse R, Tiemann M, Lennert K, Huhn D, for the Kiel Lymphoma Study Group: Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COMBLAM/IMVP-16 regimen. Ann Intern Med 117:364, 1992
40. Karakas T, Bergman L, Stutte HJ, Jäger E, Knuth A, Weidmann E, Mitrou PS, Hoelzer D: Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high grade B-cell lymphomas. Leuk Lymphoma 24:121, 1996
41. Siegert W, Nerl C, Meuthen I, Zahn T, Brack N, Lennert J, Hunn D: Recombinant human interferon-a in the treatment of angioimmunoblastic lymphadenopathy: Results in 12 patients. Leukemia 10:892, 1991
42. Cheng AL, Chen CC, Tien HF, Lay JD, Chen BR, Pu YS, Hong RL, Shen MC, Wang CH, Chen YC: Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study. J Clin Oncol 12:1185, 1994
43. Gisselbrecht C, Maraninchi D, Pico JL, Milpied N, Coiffier B, Divine M, Tiberghien P, Bosly A, Tilly H, Boulat O, Brandely M: Interleukin-2 treatment in lymphoma: A phase II multicenter study. Blood 83:2081, 1994
44. Murayama T, Imoto S, Takahashi T, Ito M, Matozaki S, Nakagawa T: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A. Cancer 69:2567, 1992